PREVALENCE OF OTHER DIABETES-ASSOCIATED COMPLICATIONS AND ITS IMPACT ON HEALTH CARE CHARGES AMONG PATIENTS WITH DIABETIC NEUROPATHY

Author(s)

Yang Zhao, PhD, Sr. Health Outcomes Scientist, Wenyu Ye, PhD, Statistician, Kristina S. Boye, RPh, MPH, PhD, Senior Health Outcomes Scientist, John Holcombe, MD, Medical Gellow, Jerry Hall, MD, Research Physician, Ralph Swindle, PhD, Research scientistEli Lilly and Company, Indianapolis, IN, USA

Objective: Diabetic neuropathy (DN) is one of the most common complications associated with diabetes. Other diabetes-related complications include depression, cardiovascular disease, stroke, renal complications, skin problems, visual impairment, and amputation. This study assesses the prevalence of other diabetes-related complications and its marginal contribution on medical charges among DN patients. Methods: Commercially insured patients aged 18-64 with at least 1 claim of DN anytime between July 2004 and June 2005 (Year 1) enrolled in a large health plan were selected. A demographically-matched control cohort of patients with diabetes was constructed via propensity scoring with a 10:1 ratio to DN cohort. Both DN patients and controls had 12 months of continuous enrollment in both Year 1 and Year 2 (July 2005-June 2006). The prevalence of other diabetes-associated complications was compared between DN patients and controls. Using multivariate regressions, we examined the marginal contribution of =1 other diabetes-related complications on Year 2 medical charges for both cohorts controlling for comorbidities. We also assessed the impact of DN on medical charges. Results: Fewer DN patients (11% out of 8655) had no other diabetes-related complications than controls (24% out of 86,550). Prevalence was statistically higher for all other diabetes-related complications in the DN group than in the control cohort with heart disease being the most common in both groups (76% for DN vs. 68% for controls). Controlling for comorbidities, patients with = 1 other diabetes-related complications had statistically higher pharmacy and total medical charges for both DN and controls. Charges were also higher for DN patients among those with or without other diabetes-related complications. Conclusion: Conclusions: DN can occur in absence of other diabetes-related complications. DN and other diabetes-related complications have significant impact on medical charges.

Conference/Value in Health Info

2008-05, ISPOR 2008, Toronto, Ontario, Canada

Value in Health, Vol. 11, No. 3 (May/June 2008)

Code

PDB38

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×